GTC Biotherapeutics (fka GTCB)

[nivasvs]

There will be a separate session on Atryn by Leo/GTCB.

See Page 7 of the link.


http://www.isth2007.com/final/Lunch_Sessions.pdf

GTC Biotherapeutics / LEO Pharma

ATryn®, the first recombinant antithrombin; innovation or alternative?
Chairperson: M. von Depka

Introduction & Welcome
M. von Depka 13:00 - 13:05

The transgenic production system; an emphasis on safety & purity
H. Meade 13:05 - 13:20

ATryn®, an alternative to plasma derived antithrombin
M. von Depka 13:20 - 13:35

Discussion
Chairpersons and Faculty 13:35 - 13:45